Evidence map›Paper›PMID 24453967›Full record

ArticlePLoS pathogens2014

Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose.

Bernhard Krismer, Manuel Liebeke, Daniela Janek, Mulugeta Nega, Maren Rautenberg, Gabriele Hornig, Clemens Unger, Christopher Weidenmaier, Michael Lalk, Andreas Peschel

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 219 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. D-alanine aminotransferase (Dat) promotesbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Transcriptional Reprogramming ofInternational journal of molecular sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Nasal microbiome inhabitants with anti-Microbiology spectrum · 2025
    Article
  12. Article
  13. Journal of virology · 2025
    Article
  14. Journal of bacteriology · 2025
    Review
  15. iScience · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The global proteome ofFrontiers in cellular and infection microbiology · 2025
    Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bernhard KrismerInterfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, Eberhard-Karls-University Tübingen, Tübingen, Germany ; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Manuel LiebekeInstitute of Pharmacy, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany.
Daniela JanekInterfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, Eberhard-Karls-University Tübingen, Tübingen, Germany ; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Mulugeta NegaInterfaculty Institute of Microbiology and Infection Medicine, Microbial Genetics, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Maren RautenbergInterfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, Eberhard-Karls-University Tübingen, Tübingen, Germany ; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Gabriele HornigInterfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, Eberhard-Karls-University Tübingen, Tübingen, Germany ; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Clemens UngerInstitute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Christopher WeidenmaierInterfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, Eberhard-Karls-University Tübingen, Tübingen, Germany ; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Michael LalkInstitute of Pharmacy, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany.
Andreas PeschelInterfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, Eberhard-Karls-University Tübingen, Tübingen, Germany ; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
German Center for Infection Research · DEUniversity of Tübingen · DEUniversität Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colonization of the human nose by Staphylococcus aureus in one-third of the population represents a major risk factor for invasive infections. The basis for adaptation of S. aureus to this specific habitat and reasons for the human predisposition to become colonized have remained largely unknown. Human nasal secretions were analyzed by metabolomics and found to contain potential nutrients in rather low amounts. No significant differences were found between S. aureus carriers and non-carriers, indicating that carriage is not associated with individual differences in nutrient supply. A synthetic nasal medium (SNM3) was composed based on the metabolomics data that permits consistent growth of S. aureus isolates. Key genes were expressed in SNM3 in a similar way as in the human nose, indicating that SNM3 represents a suitable surrogate environment for in vitro simulation studies. While the majority of S. aureus strains grew well in SNM3, most of the tested coagulase-negative staphylococci (CoNS) had major problems to multiply in SNM3 supporting the notion that CoNS are less well adapted to the nose and colonize preferentially the human skin. Global gene expression analysis revealed that, during growth in SNM3, S. aureus depends heavily on de novo synthesis of methionine. Accordingly, the methionine-biosynthesis enzyme cysteine-γ-synthase (MetI) was indispensable for growth in SNM3, and the MetI inhibitor DL-propargylglycine inhibited S. aureus growth in SNM3 but not in the presence of methionine. Of note, metI was strongly up-regulated by S. aureus in human noses, and metI mutants were strongly abrogated in their capacity to colonize the noses of cotton rats. These findings indicate that the methionine biosynthetic pathway may include promising antimicrobial targets that have previously remained unrecognized. Hence, exploring the environmental conditions facultative pathogens are exposed to during colonization can be useful for understanding niche adaptation and identifying targets for new antimicrobial strategies.

Indexed as

Adaptation, PhysiologicalAdultAnimalsBacterial ProteinsFemaleGene Expression Regulation, BacterialHumansMaleMetabolomicsNasal CavityRatsSigmodontinaeStaphylococcus aureusBacterial Proteins

Identifiers

PMID24453967
PMCPMC3894218
OpenAlexW1986787331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.